Interesting thought experiment, especially in light of the recent Amazon+JP Morgan+Berkshire Hathaway collaboration.
The N.Y. Times states that:
Planning for the new company is being led by Marvelle Sullivan Berchtold, a JPMorgan managing director who was previously head of the Swiss drugmaker Novartis’s mergers and acquisitions strategy; Todd Combs, an investment officer at Berkshire Hathaway; and Beth Galetti, a senior vice president at Amazon.
Looks like a great idea but it still needs works as some people could just use someone else’s profile to get some prescriptions. But obviously this could be a great idea taking in consideration all the benefits.